EMBO reports
EMBO reports
SEARCH Go
My AccountSubmit manuscriptSubscribeRegisterHelp
Journal home
Press releases
Aims and scope
Authors and referees
 Guide for authors
 Guide for referees
 Contact editors
 Advisors & Advisory
 Editorial Board
 Submit a Manuscript
Customer Services
 Subscriptions
 Order sample copy
 Purchase articles
 Reprints and
  permissions
 Contact NPG
 Advertising
EMBO
EMBO
www.embo.org

scientific report
EMBO reports 8, 5, 504–509 (2007)
doi:10.1038/sj.embor.7400934
AOP Published online: 30 March 2007

S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes

Taku Saito1, Toshiyuki Ikeda2, Kozo Nakamura1, Ung-il Chung2 & Hiroshi Kawaguchi1
1  Department of Sensory and Motor System Medicine, Faculty of Medicine, Center for Disease Biology and Integrative Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo, Tokyo 113-8655, Japan
2  Faculty of Medicine, Center for Disease Biology and Integrative Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo, Tokyo 113-8655, Japan


To whom correspondence should be addressed
Hiroshi Kawaguchi  Tel: +81 33815 5411 ext. 30473; Fax: +81 33818 4082; E-mail: kawaguchi-ort@h.u-tokyo.ac.jp


Received 7 August 2006; Accepted 29 January 2007; Published online 30 March 2007.
Abstract

Transcription factor SOX9 (sex-determining region Y-type high mobility group box 9) and its coactivators SOX5 and SOX6 (the SOX trio) induce early-stage chondrocyte differentiation and suppress its terminal stage. To identify possible targets of the SOX trio, we carried out a microarray analysis and identified S100A1 and S100B as possible target molecules. S100 protein expression was localized in late proliferative and pre-hypertrophic chondrocytes of the mouse growth plate. Overexpression of S100A1, S100B or their combination in cultured chondrogenic cells did not induce early differentiation, but suppressed hypertrophic differentiation and mineralization. Silencing of both S100A1 and S100B stimulated terminal differentiation and reversed the SOX-trio-mediated inhibition. Finally, luciferase reporter, electrophoretic mobility shift and chromatin immunoprecipitation analyses showed that transcription of both S100 proteins is induced by the SOX trio, and also identified their respective enhancer elements in the 5'-end flanking region. We conclude that S100A1 and S100B are transcriptional targets of the SOX trio and mediate its inhibition of terminal differentiation of chondrocytes.

top go to top
This article

Email
Email link to a friend
Download PDF Download PDF
 Full TextFull text
 rights and permissions Rights and permissions
 order commercial reprints Reprints
Privacy PolicyCopyright © 2007 by the European Molecular Biology Organization